A61K 9/143
With inorganic compounds
Official title: {with inorganic compounds}
A61K9/143 (With inorganic compounds) appears on 600 US grants and 996 published applications in this corpus.
Search patents in A61K- Granted patents
- 600
- Published applications
- 996
- Assignees
- 547
- Inventors
- 2,016
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 6 | 0 |
| 1987 | 11 | 0 |
| 1988 | 9 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 7 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 10 | 2 |
| 2002 | 8 | 12 |
| 2003 | 9 | 23 |
| 2004 | 5 | 10 |
| 2005 | 8 | 25 |
| 2006 | 7 | 31 |
| 2007 | 3 | 27 |
| 2008 | 6 | 28 |
| 2009 | 5 | 26 |
| 2010 | 12 | 38 |
| 2011 | 6 | 30 |
| 2012 | 13 | 32 |
| 2013 | 23 | 36 |
| 2014 | 32 | 46 |
| 2015 | 34 | 51 |
| 2016 | 31 | 45 |
| 2017 | 28 | 46 |
| 2018 | 31 | 49 |
| 2019 | 33 | 42 |
| 2020 | 24 | 58 |
| 2021 | 21 | 62 |
| 2022 | 36 | 74 |
| 2023 | 38 | 58 |
| 2024 | 32 | 50 |
| 2025 | 35 | 62 |
| 2026 | 24 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Stable lyophilized composition of pemetrexed dipotassium1 Sep 2026US 12,721,811 B1AVYXA Pharma
- Wound treatment25 Aug 2026US 12,714,703 B2Marie's Original Formulas LLC
- Treatment approach by targeted delivery of bioactive molecules bio modulated ceramics18 Aug 2026US 12,708,603 B2Moroxite AB
- Treatment with powdered intranasal epinephrine14 Jul 2026US 12,678,402 B2Nasus Pharma Ltd.
- Method of treating cancer cells using CaMoO4/CaSiO3/g-C3N4 crystalline nanocomposite material9 Jun 2026US 12,648,909 B1Imam Mohammad Ibn Saud Islamic University
- Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarction17 Sep 2026US 2026/0272826 A1Theaprin Pharmaceuticals Inc.
- Soluble curcumin and its derivatives20 Aug 2026US 2026/0240791 A1ThermoLife International, LLC
- Composition containing self-assembled structure and freeze-dried product thereof20 Aug 2026US 2026/0241008 A1Resonac Corporation
- Co-crystals with thin-film freeze-drying process to enhance delivery6 Aug 2026US 2026/0224490 A1Board of Regents, The University of Texas System
- Controlled release delivery of low water solubility compounds via oral administration6 Aug 2026US 2026/0224497 A1Starton Therapeutics, Inc.
Most cited
By later US patents
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Mesoporous materials and methods of making the same166US 6,696,258 B1Drexel University · 2004
- Method of producing a sustained-release preparation144US 6,197,350 B1Takeda Chemical Industries, Ltd. · 2001
- Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix77US 6,998,137 B2MacroMed, Inc. · 2006
- Pharmaceutical composition and administrations thereof76US 8,883,206 B2Vertex Pharmaceuticals Incorporated · 2014